chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Information has been received from a female consumer (age unknown) who on an unspecified date was vaccinated (route unknown) with a dose of PNEUMOVAX (manufacturer unknown, lot # unknown) and a dose of influenza virus vaccine (unspecified, manufacturer unknown).  Subsequently, after receiving the vaccinations, on an unknown date, the patient experienced injection site reactions.  It is unknown if the patient sought medical attention.  No product quality complaint was involved.  Additional information has been requested.
Patient had her shot at 7:23am. She said she didn't feel well and her tongue felt funny. She stated similar issues with shot 1. She reports hx of anaphylaxis to penicillin. I gave benadryl 50mg po at 7:47am. Her bp was 137/85, pulse 67, and pulse ox was 98%. Patient left at 7:58. She states she just wanted to go home.
Systemic: Fainting / Unresponsive-Medium, Systemic: Fell from chair and hit head on floor - small gash on bridge of nose-Medium, Systemic: Flushed / Sweating-Medium, Systemic: Headache-Medium, Systemic: Hypotension-Medium, Systemic: Weakness-Medium, Additional Details: Within 5 minutes of vaccination, pt fell from sitting position in chair to the ground.  Pt hit his head and had small gash on bridge of nose.  When I got to him, his eyes openned and he knew what happenned.  Called 911.  He laid on ground while we had NP check blood pressure, pulse, and O2 levels.  Pt was stable and walked out with EMS to be checked out.
tinnitus; This spontaneous case was reported by a consumer and describes the occurrence of TINNITUS (tinnitus) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 prophylaxis.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced TINNITUS (tinnitus). At the time of the report, TINNITUS (tinnitus) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were reported. The reporter saw a doctor who posted that he experienced tinnitus himself. He said that it would take about a year for it to go away. No treatment medications were reported.
Arm hurting; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Arm hurting) in an 80-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 023M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 18-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 2 dosage form. On 19-Feb-2021, the patient experienced PAIN IN EXTREMITY (Arm hurting). At the time of the report, PAIN IN EXTREMITY (Arm hurting) outcome was unknown.            No concomitant medications were provided.  No treatment details were provided.
Dizziness/lightheadedness; Pain to the right arm; Trouble holding on to things; Headaches; This is a non-serious spontaneous case initially received from other non-health professional on 04-Dec-2018, concerning a female patient of an unspecified age.  On 02-Oct-2018, the patient was administered Afluria (TIV) [influenza vaccine, dose, route of administration, anatomical location, batch number and expiry date: not reported] for an unknown indication.  On an unspecified day in 2018, after vaccination, the patient experienced pain to the right arm, dizziness, headaches, light-headedness and had trouble holding on to things.  The outcome of the events was not reported.  Non-significant follow-up information received on 26-Feb-2019: The Info number (SEQ19-00043) was added in the additional information. No changes were done in the narrative.; Reporter's Comments: A female patient of an unspecified age experienced pain to the right arm, dizziness, headaches, light-headedness and had trouble holding on to things, unspecified days after the administration of Afluria (TIV). The causality of the events was unassessable due to lack of information regarding onset latency.
Memory loss after vaccination; This is a spontaneous report received from contactable reporter(s) (Other HCP) from a sales representative.  A patient (no qualifiers provided) received BNT162b2 (BNT162B2), as dose number unknown, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: AMNESIA (non-serious), outcome "unknown", described as "Memory loss after vaccination".  Additional information: Description of Event: Memory loss after vaccination. Event took place after use of product.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
This spontaneous report as received from a physician refers to a unspecified number of patient of unknown age. The unspecified patients medical history was not reported. The physician stated that her refrigerator and freezer units began to have temperature excursions as of 05-MAY-2014. RECOMBIVAX HB was improperly exposed to 29F for multiple unspecified excursions (many more than 2 cycles into the freezing range) since 05-MAY-2014 and also to 49F for 12 hours. ON unspecified dates since 05-MAY-2014, an unspecified number of patients received RECOMBIVAX HB which was improperly stored. No product complaint was reported for RECOMBIVAX HB.   This case is linked to 1411USA004655, 1411USA004432, 1411USA004434, 1411USA004435, 1411USA004436, 1411USA003347, 1411USA004438, 1411USA004439, 1411USA004440, 1411USA004441, and 1411USA004442
This spontaneous case was reported by a physician and describes the occurrence of OCULAR DISCOMFORT (eye pressure), OCULAR HYPERAEMIA (left eye redness), HYPERHIDROSIS (sweats), VACCINATION SITE PAIN (Arm Soreness - Near Injection Site) and MYALGIA (Body aches) in a 68-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 012A21A and 042498) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 05-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Mar-2021, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 05-Mar-2021, the patient experienced OCULAR DISCOMFORT (eye pressure), OCULAR HYPERAEMIA (left eye redness), HYPERHIDROSIS (sweats), VACCINATION SITE PAIN (Arm Soreness - Near Injection Site), MYALGIA (Body aches) and PYREXIA (Fever - Temperature Unknown). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency and DEXTROMETHORPHAN HYDROBROMIDE, DOXYLAMINE SUCCINATE, EPHEDRINE SULFATE, ETHANOL, PARACETAMOL (NYQUIL) at an unspecified dose and frequency. On 08-Mar-2021, OCULAR DISCOMFORT (eye pressure), OCULAR HYPERAEMIA (left eye redness), HYPERHIDROSIS (sweats), VACCINATION SITE PAIN (Arm Soreness - Near Injection Site), MYALGIA (Body aches) and PYREXIA (Fever - Temperature Unknown) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
Pt reported right arm soreness for two days after injection; no other adverse reactions were reported. Patient received 0.5 mL for his third Moderna dose, but he is not defined as severely immunocompromised by the CDC.
Extreme dizziness to the point of falling down even when attempted to just sit up, lasting around18 hours. Extreme headache with mild fever and other flu like symptoms. The reason why I am reporting this is that in my entire live I have have been so dizzy and unbalanced. I literally could not even sit up, I was super foggy and achey.  By 3 days all the symptoms cleared.
Rec'd Covid vaccine after 15 min obs stated she felt "swooney, dizzy, like" BP 168/86 HR 68 states she has a hx of HTN she usually runs 120's/70's Monitored for another 25 min BP ranging 157/87 - 173/86, prior to leaving states she was not feeling dizzy anymore BP 164/88 HR 69, and wanted to go back to work. Could not find anyone to take care of her patients and was concerned. Coworker states they would monitor her.
Shingles developed on Tuesday, April 6, (4 days after the first dose of the Covid 19 Pfizer vaccine). My physican was contacted on April 7 and Valacyclovir HCL 1 gram (3x daily for 7 days) was prescribed. It took until approximately April 22 for the shingles virus to heal.
Narrative: COVID infection following COVID vaccine series 07/28 Janssen, dose #1 08/22 pt cc: fever, nausea, rhinorrhea exposure; unknown 08/2 COVID swab, result: detected 08/23 SARS-COV-2 Variant Sequencing result: pending
Chills; Muscle aches; This case was reported by a nurse via sales rep and described the occurrence of chills in a adult female patient who received Herpes zoster (Shingrix) for prophylaxis.   In January 2019, the patient received the 2nd dose of Shingrix. On an unknown date, less than a year after receiving Shingrix, the patient experienced chills and muscle ache. The patient was treated with analgesic, nos, analgesic, nos, analgesic, nos (Analgesic). On an unknown date, the outcome of the chills and muscle ache were recovered/resolved.   It was unknown if the reporter considered the chills and muscle ache to be related to Shingrix.  Additional details were provided as follows: The lot number was not known for Shingrix. The patient experienced chills and muscle aches, but no fever. Both the events subsided within 24 hours. The reporter given permission for follow up.
COVID-19 Treatment; COVID 19 Treatment; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 57-year-old male patient received BNT162b2 (BNT162B2), on 26Oct2021 as dose 3 (booster), single (Batch/Lot number: unknown) at the age of 57 years, in right arm for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown) and as dose 2, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: COVID-19 (medically significant) with onset Sep2022, outcome "not recovered", described as "COVID 19 Treatment"; DRUG INEFFECTIVE (medically significant) with onset Sep2022, outcome "not recovered", described as "COVID-19 Treatment". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Negative, notes: COVID rebound after being negative; Positive, notes: Positive now for a week (self test and test at (pharmacy name withheld) to confirm); Positive, notes: Positive now for a week (self test and test at (pharmacy name withheld) to confirm); Negative, notes: negative for a few days. Therapeutic measures were taken as a result of drug ineffective, covid-19.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Electrolyte that was not normal 0.9; This is a spontaneous report received from a contactable reporter(s) (Pharmacist).  A 76-year-old female patient received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 10Nov2022 as dose number unknown (booster), single (Batch/Lot number: unknown) at the age of 76 years for covid-19 immunisation. The patient's relevant medical history included: "Hypothyroidism" (unspecified if ongoing); "Depression" (unspecified if ongoing); "Hyponatremia" (unspecified if ongoing); "TIA" (unspecified if ongoing); "cardiacally impaired" (unspecified if ongoing). Concomitant medication(s) included: ALPRAZOLAM; GABAPENTIN; LOVENOX [LEVOFLOXACIN]. Vaccination history included: BNT162b2;BNT162b2 omi ba.4-5 (DOSE NUMBER UNKNOWN (BOOSTER), SINGLE), administration date: 01Oct2022, when the patient was 75-year-old, for Covid-19 Immunization; Covid-19 vaccine (Primary immunization series completed; unknown manufacturer), for Covid-19 Immunization. The following information was reported: BLOOD ELECTROLYTES ABNORMAL (non-serious), outcome "unknown", described as "Electrolyte that was not normal 0.9". Relevant laboratory tests and procedures are available in the appropriate section. Additional information: the patient was given again the bivalent dose on 10Nov2022 which was almost one month apart from the last booster on 01Oct2022. The pharmacist reported that the patient was on 23 medications or whatever the pharmacist told. She was diagnosed with EBA (not clarified), depression, cardiacaly impaired, hypothyroidism, TIA, history of hyponatremia. Her electrolyte was not normal.  The information on the batch/lot number for BNT162b2, BNT162b2 omi ba.4-5 has been requested and will be submitted if and when received.
Ventricular tachycardia and presumed myocarditis.    Was feeling well until 4 days after vaccine developed palpitations found to have monomorphic VT followed by cardiac arrest.
Previously healthy 50 yr. old male (49 yo. at time of cancer diagnosis) Diagnosed with Stage-4 Medullary Thyroid Cancer (MTC): 03/2022 Total thyroidectomy and removal of several lymph nodes: 06/09/2022  First Pfizer mRNA vaccination date: 04/10/21 Second Pfizer mRNA vaccination date: 05/01/21  Ongoing symptoms (04/19/2023): joint pain/inflammation, deteriorated/blurred vision, chronic diarrhea, chest pain/inflammation, anxiety, insomnia, sweating, poor temperature regulation  Related medical billing to date is in the neighborhood of $100k
Vaginal itching and irritation, abdominal pains, headaches, dizziness, chronic low grade fever, leg pains, rapid heart beat.
Constant nausea/diarrhea, dizziness, throat tightening sensation, warm heavy feeling across chest and neck that comes in waves, headache, head pressure, severe muscle fatigue, shortness of breath, anxiety and feelings of panic, tachycardia (up to 150? beats per minute)
Chills/Teeth chattering; Phlegm congestion in nose and throat; Phlegm congestion in nose and throat; Felt shaky/nervous; She felt fatigue; Tightening her muscles; Her joints ached; Muscle and body aches; Muscle and body aches; Brain fog; She then started to have a headache after that; This is a spontaneous report from a contactable consumer, the patient.  A 52-year-old female patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EL8982), via an unspecified route of administration on 19Jan2021 (at the age of 52-years-old) in the left arm as a single dose for COVID-19 immunization.  Medical history was not reported.  Ongoing concomitant medications included biotin (MANUFACTURER UNKNOWN), fish oil (MANUFACTURER UNKNOWN), vitamin D3 (MANUFACTURER UNKNOWN),and cyanocobalamin (VITAMIN B12); all from unknown dates. The patient also took multivitamins from an unknown date and unknown if ongoing. The patient previously received the first dose of BNT162B2 (at the age of 52-years-old; Lot Number: EL942 or EL0142) on 29Dec2020 in the left arm for COVID-19 immunization and experienced headache and fatigue.  The patient did not receive any other vaccines within four weeks prior to the vaccination except the first dose of the vaccine. On 19Jan2021, the patient experienced shaky/nervous, chills/teeth chattering, muscle and body aches, fatigue, tightening her muscles, brain fog, phlegm congestion in her nose and throat, joints aches, and headache. On 20Jan2021, she stayed well hydrated, but she slept a lot. However, she felt fatigue, had the headache off and on, tight and sore from muscle aches. Therapeutic measures were taken for the chills/teeth chattering, muscle and body aches, joint aches, and headache and included treatment with ibuprofen (ADVIL LIQUIGELS).  The clinical outcomes of chills/teeth chattering and phlegm congestion in her nose and throat, were recovered on 21Jan2021 and Jan2021, respectively.  The clinical outcomes of the felt shaky/nervous, fatigue, tightening her muscles, and joint aches were unknown; while that of the muscle and body aches, headache, and brain fog were not recovered.; Sender's Comments: Linked Report(s) : same reporter/patient, different vaccine dose and event.
Information has been received from a medical assistant referring to a patient of unknown age and gender. Pertinent medical history or drug allergies/drug reactions were not reported. On 03-JUN-2015, the patient was vaccinated with a dose of improperly stored ROTATEQ (lot # K023159, expiration date 26-JUL-2016) (dose and route were not reported). The vaccine was exposed to 31.1 F for a cumulative time of 411.70 hours. Concomitant medication was not reported. No adverse effect was reported. This is one of two reports received from the same source. Additional information has been requested.
I received the vaccine around 7:55 am in my left arm. I waited  around the appropriate time then drove home. No problems until 12:30 or so. I was resting in my bed and immediate felt my heart start to race. I checked it with my pulse oximeter and my rate had shot up to 148. I got up and tried some maneuvers to try to get it down. It then went up to 152. I told my husband to call EMS. I also contact my co-worker. She is a physician and she agreed with taking some benadryl. I took 25 mgs of benadryl. EMS arrived about 10 minutes later. they monitor my blood pressure and heart rate. it did come down but remained around 100. I then went to ER by car for evaluation.
This spontaneous report as received from a other nurse practitioner via a company representative refers to a female patient of unknown age. On an unknown date the patient was vaccinated with GARDASIL dose 1, (lot number and expiry date unknown) (dosing regimen and frequency unknown). No concomitant medications were reported. On an unknown date the patient experienced hives and rash after receiving her second dose of GARDASIL. The patient sought medical attention and made a phone call to the nurse practitioner on an unknown date. The patient did not receive any treatment for the events. The outcome of hives and rash was unknown. The action taken with the therapy with GARDASIL was unknown. The relatedness of the events to the therapy with GARDASIL was unknown. No product quality complaint was reported. Additional information has been requested.
1 week after shot - red raised rash - itches on arm below injection site was given betamethasone dipropionate 0.05% cream.
Slight swelling in my arm, incredibly tender/sore approximately 3 hours after receiving vaccine. Following morning I noticed I had a fever of approximately 100 degrees. Took ibuprofen at approximately 11pm on the day I received the injection.
One of two pt's who experienced syncope (vaso-vagal response) immediately following immun; Pt recovered & no tx given;
Woke up that morning with nausea. Tested positive on a COVID-19 test that day. Doctor prescribed PAXLOVID and something for nausea. Symptoms mild and lasted 3 days at most.
About 5 hours after receiving SHINGRIX, patient experienced severe headache and heat sensation on her face. The area affected starts below the right eye and radiated up the right side for her face to the back right side of her head. She said it was throbbing with a hot nerve pain limited to the specified area. She also experienced increased blood pressure of 167/77. She went to bed and felt better the next day, but was having intermittent pain and heat on the right side of her face/head for the next few days.
On November 09, 2022, I had a severe headache. On November 12, 2023, I went to a walk-in clinic. From there, I was referred to a local hospital. I received a CAT scan and a CAT scan with contrasting dye. I was informed I had a brain aneurism. They were going to medevac me to another location, but I spoke with a doctor back home and chose to fly back home instead. On December 5, 2022, I was admitted to the hospital and had an angiogram. It showed the aneurism was leaking. On December 06, 2022, I had brain surgery to correct the aneurism. I spent five days in ICU. I returned home on December 12, 2022. I spent 6 weeks on Plavix and had extreme difficulty breathing the entire six weeks. On January 18, 2023, I revisited the doctor. He took me off Plavix. Two days later, I returned to normal breathing and normal activities. I've been good ever since.
A non-serious spontaneous report of positive influenza test has been received from a registered nurse concerning a seven-year-old male child, subsequent to FLUMIST. No medical history or concomitant medications were reported for this child. The patient received a single dose of FLUMIST on 12-Sep-2009. On 17-Sep-2009 the patient presented with flu like symptoms, an influenza test was positive. No outcome has been reported.
IPV and DTAP given in right deltoid. Two days later returned to clinic with arm red, hot, swollen from axilla to mid forearm.
pt recvd vax; t of 104.7;lethargy & tachycardia which had began that day; mom advised to cont acetaminophen & contact MD
Pt. was experiencing soreness the night of the vaccine in the arm of her tetanus shot. The next day she noticed swelling and redness at the site of vaccination that was as big as her palm. She noticed a hard knot in that arm as well. She iced her arm all weekend and the swelling has gotten worse. Today, Monday October 22nd, she came to the clinic and her arm has a hard knot and is slightly red and bruised. She said her pain is tolerable. It was slightly red to the touch.
Pain in upper right back when I inhale. Mild headache. Fatigue. Soreness at site of injection
Vulvovaginal aphthous ulcers. This was a repeat symptomatic outbreak. 1st episode occurred after COVID-19 infection in October of 2020.
Second morning after shot woke up with extremely blurry in right eye that improved slowly as the day went by, but not to previous vision.  Same problem the morning after sleep and over the next day.  Went to opthamalogist on Monday, Feb 1 who immediately referred to retina specialist, seen Feb 2.  Have ongoing treatment for glaucoma, has been stable for years.  I am not claiming this started because of the shot, but it was so close after that I thought I should report out of an excess of caution.
Local redness, with swelling and "hard knot" under skin "approx 4 inches diameter". Chills/fever x 2 days - Undocumented by patient. Nausea. Headache.
Severe chills, fever 101.5, fatigue and headache started at 11:30 pm Thursday night . Fever, fatigue  persisted through Friday even tough taking Tylenol. It would drop to 99 with Tylenol, then spike to over 101 at 6 hours (right before next dose of Tylenol was due). Fever broke Friday night, continuous sweat for 6 hours necessitating bed change at 4 am. Saturday morning temperature normal, no symptoms left.
Very Very Very sick with flu after taking flu shot; Initial information received on 14-Nov-2020 regarding an unsolicited valid non-serious social media case received from a consumer/non-hcp.  This case involves a female patient who was very very very sick with flu after (influenza), while she received vaccine INFLUENZA VACCINE.  Medical history, medical treatment, vaccination and family history of the patient were not provided. Concomitant medication was not reported.   On an unknown date, the patient received a dose of suspect INFLUENZA VACCINE (produced by unknown manufacturer) (lot number and expiration date not reported) via unknown route in unknown administration site for prophylactic vaccination.  On an unknown date, the patient was very very very sick with flu (influenza) (Unknown latency) following the administration of INFLUENZA VACCINE.  Final diagnosis was influenza.  No relevant laboratory test was reported.  It was not reported if the patient received a corrective treatment.  The outcome was reported as unknown.  There will be no information available on the batch number for this case.
1-2 days p/vax began having a sore back (lower);pain progressed to the lt leg & has remained;pain is severe, unable to sleep/walk or do any physical activity comfortable;